Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3094% above fair value
$88.81+0.19 (+0.21%)
Close on Nov 12, 2026Market cap $15.12BP/E 99.8Yield –
Solventum total assets
Total assets on the balance sheet at the end of each period.
Solventum's total assets was $14.17B at Sep 30, 2026. For fiscal 2025 it was $14.29B, down 1.1% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.29B | -1.1% |
| FY2024 | Dec 31, 2024 | $14.46B | +3.7% |
| FY2023 | Dec 31, 2023 | $13.94B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $14.17B | +1.4% |
| Q2 FY2026 | Jun 30, 2026 | $14.24B | -5.5% |
| Q1 FY2026 | Mar 31, 2026 | $14.10B | -3.0% |
| Q4 FY2025 | Dec 31, 2025 | $14.29B | -1.1% |
| Q3 FY2025 | Sep 30, 2025 | $13.97B | -5.2% |
| Q2 FY2025 | Jun 30, 2025 | $15.07B | +3.4% |
| Q1 FY2025 | Mar 31, 2025 | $14.53B | -1.3% |
| Q4 FY2024 | Dec 31, 2024 | $14.46B | +3.7% |
| Q3 FY2024 | Sep 30, 2024 | $14.75B | – |
| Q2 FY2024 | Jun 30, 2024 | $14.58B | – |
| Q1 FY2024 | Mar 31, 2024 | $14.71B | – |
| Q4 FY2023 | Dec 31, 2023 | $13.94B | – |
See a number that looks wrong?